Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase06 Feb 2026Roper Technologies IncROP:NSQThomas P. JoyceIndependent Director1,400358.46
USD
501.84k USD
Sale06 Feb 2026Broadridge Financial Solutions IncBR:NYQRobert N. DuelksIndependent Director253192.60
USD
48.73k USD
Sale05 Feb 2026Teradyne IncTER:NSQMercedes JohnsonIndependent Director625266.98
USD
166.86k USD
Sale05 Feb 2026Ziprecruiter IncZIP:NYQIan SiegelChief Executive Officer and Chairman of the Board9,7221.97
USD
19.15k USD
Purchase05 Feb 2026United Utilities Group PLCUU.:LSEMarina M WyattNon-Executive Director2,40012.69
GBP
30.47k GBP
Sale05 Feb 2026Merchants BancorpMBIN:NAQMichael F. PetrieChief Executive Officer; Chairman of the Board of the Company and Merchants Bank of Indiana2,03420.20
USD
41.09k USD
Purchase05 Feb 2026Arcontech Group PLCARC:LSEMatthew David JeffsExecutive Director,Chief Executive Officer20,0000.7646
GBP
15.29k GBP
Sale05 Feb 2026Waterstone Financial IncWSBF:NSQDouglas S. GordonDirector18,71618.25
USD
341.57k USD
Sale05 Feb 2026East West Bancorp IncEWBC:NSQJack C. LiuIndependent Director1,421119.00
USD
169.10k USD
Sale05 Feb 2026Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer5,37678.38
USD
421.37k USD
Sale05 Feb 2026Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer4,62478.94
USD
365.00k USD
Purchase05 Feb 2026Veradermics IncMANE:NYQPatrick G. EnrightIndependent Director192,64717.00
USD
3.27m USD
Purchase05 Feb 2026Veradermics IncMANE:NYQPatrick G. EnrightIndependent Director882,35317.00
USD
15.00m USD
Purchase05 Feb 2026Veradermics IncMANE:NYQJohn W. ChildsIndependent Director294,11717.00
USD
5.00m USD
Purchase05 Feb 2026Veradermics IncMANE:NYQVlad CoricIndependent Director58,82317.00
USD
999.99k USD
22862 total results
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.